Life Sciences News

Technology Trends We’d Like to See More of in 2017

January 26, 2017

We live in a world where new technology is constantly and consistently advancing and new companies are born every day. In 2014, the recession maintained its grasp on American ingenuity as entrepreneurship hit a 20-year low. However, according to the Kauffman Index for 2016, startup activity rebounded last year, going up for the second year in […]

Read More

MBF Therapeutics Teams Up With Wistar

December 1, 2016

A Montgomery County company seeking to develop ways to treat cancer in dogs and cats has secured a new partner and new investment to help it achieve its goals. MBF Therapeutics of Ambler raised more than $100,000 in new capital from private investors and converted existing debt and notes into equity in a $1.1 million […]

Read More

Essential Medical Inc. Announces Successful Live Case at TCT

November 8, 2016

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today the first live MANTA case at the Transcatheter Therapeutics conference (TCT) in Washington DC.  TCT is the largest annual interventional cardiology conference in North America. The case was performed live on Monday October 31st by […]

Read More

QR Pharma Raises $800,000 of Series A Preferred Stock

October 28, 2016

QR Pharma, Inc., a privately held biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s, Parkinson’s and other neurodegenerative diseases, has closed on $800,000 of Series A Preferred Stock financing. Existing investors Robin Hood Ventures and individual angels filled this round. QR Pharma will use the funding to continue to develop its lead compound, […]

Read More

ZSX Medical wins $100K at angel group Keiretsu Forum’s annual expo

October 28, 2016

ZSX Medical, a medical device company based out of a life sciences coworking space on Drexel’s campus, won the top prize — a $100,000 investment — at the Keiretsu Forum Mid-Atlantic’s fourth annual Angel Capital Expo on Wednesday. At the angel group’s expo, held at Drexel University’s Bossone Research Center, 15 companies pitched. Following the […]

Read More

FDA Approves Janssen Biotech’s Drug for Crohn’s Disease

September 30, 2016

The Food and Drug Administration approved expanding the label for Horsham-based Janssen Biotech’s Stelara product to include its use for the treating Crohn’s disease. Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract that affects about 700,000 Americans. The FDA approval of Stelara specified its use in adults 18 or older with moderately […]

Read More

Essential Medical Inc. Announces Closing on $14.9M Series B Funding

September 20, 2016

Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has completed a Series B financing of $14.9M. The round was led by Amzak Health along with original Series A investors including DSM Venturing, the venture investment arm of Royal DSM. Greg Walters, […]

Read More

RistCall replaces antiquated nurse call buttons with smart watch technology

September 20, 2016

Startup RistCall was founded August 2014 in Philadelphia, and recently completed Memphis Bioworks’ Zero to 510 medical device accelerator. Founder and CEO Srinath Vaddepally describes Ristcall as a game-changing technology, to disrupt the current nurse call button system found in hospitals and nursing homes. Ristcall has a software and a hardware component – – the […]

Read More

Greenphire Executives To Participate In INC Research And CISCRP’s ‘Inspiring Hope’ Ideathon

September 20, 2016

Greenphire, the global leader in clinical payment solutions, recently announced that it will participate in INC Research and CISCRP’s “Inspiring Hope” Ideathon, a competition designed to promote greater awareness of the importance of clinical trial participation in advancing public health. The ideathon is being held in Boston on September 27 – 28. According to CISCRP, […]

Read More

Morphotek Announces Sponsored Research Agreement With Fox Chase Cancer Center To Study Immunosuppressive Effects Of Tumor Shed Antigens To Improve Future Patient Therapies

September 13, 2016

Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a Sponsored Research Agreement (SRA) with Fox Chase Cancer Center (FCCC) to expand its research efforts into the immunosuppressive effects elicited by tumor shed antigens on the efficacy of immune-based therapies. The collaboration will utilize primary human organoid cultures derived from various […]

Read More

Previous Next